Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-02T19:05:59.345Z.
Calculation as of: 2026-10-02T19:05:59.345Z.
Quote observation: 2026-10-02T19:05:17.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: a42e17afc1a1b5c0c05c4bcc318afc1e85bdb01f5d7a677422ba224d703768eb
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Recursion Pharmaceuticals, Inc.
Market Cap
$2.13B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.49B
Free Cash Flow Yield
N/A
TTM Avg
3.15%
3Y Avg
3.15%
5Y Avg
3.15%
Market Cap
$1.74B
Free Cash Flow Yield
8.24%
TTM Avg
4.64%
3Y Avg
5.79%
5Y Avg
5.67%
Market Cap
$1.71B
Free Cash Flow Yield
N/A
TTM Avg
8.65%
3Y Avg
8.65%
5Y Avg
8.65%
Market Cap
$2.72B
Free Cash Flow Yield
2.91%
TTM Avg
3.10%
3Y Avg
2.70%
5Y Avg
2.70%
Market Cap
$1.01B
Free Cash Flow Yield
22.34%
TTM Avg
18.83%
3Y Avg
16.31%
5Y Avg
12.13%
Market Cap
$470.35M
Free Cash Flow Yield
N/A
TTM Avg
3.29%
3Y Avg
4.78%
5Y Avg
5.98%
Market Cap
$389.98M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Recursion Pharmaceuticals, Inc. (RXRX) | $2.13B | N/A | N/A | N/A | N/A |
| Beam Therapeutics Inc. (BEAM)vs › | $2.49B | N/A | 3.15% | 3.15% | 3.15% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.74B | 8.24% | 4.64% | 5.79% | 5.67% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.71B | N/A | 8.65% | 8.65% | 8.65% |
| TransMedics Group, Inc. (TMDX)vs › | $2.72B | 2.91% | 3.10% | 2.70% | 2.70% |
| Teladoc Health, Inc. (TDOC)vs › | $1.01B | 22.34% | 18.83% | 16.31% | 12.13% |
| NeoGenomics, Inc. (NEO)vs › | $470.35M | N/A | 3.29% | 4.78% | 5.98% |
| NRC Health (NRC)vs › | $459.30M | 4.71% | 3.78% | 3.98% | 3.71% |
| Shoulder Innovations, Inc. (SI)vs › | $389.98M | N/A | N/A | N/A | N/A |
| PDS Biotechnology Corporation (PDSB)vs › | $41.24M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
